20 May 2004
Reliability of interleukin-6 and interleukin-8 in distinguishing between infectious and non-infectious respiratory disorders in neonates
Irena Wojsyk-Banaszak, Jerzy SzczapaMed Sci Monit 2004; 10(2): 36-41 :: ID: 11844
Abstract
Background: Interleukin-6 and interleukin-8 are mediators of inflammatory process with high diagnostic value in early-onset neonatal sepsis. Their role in localized infection is much less known. Therefore the aim of our study was to investigate the reliability of interleukin-6 and interleukin-8 in distinguishing between infectious and non-infectious respiratory disorders in neonates.Material/Methods: The prospective study was conducted in 76 newborns. In 49 of them clinical signs of respiratory distress were present at birth, and 27 served as control group.Results: Mean value ±SEM of interleukin-6 in newborns with pneumonia was 43.11±10.37 pg/ml and in non-infected 10.48±1.53 pg/ml; p=0.000. For interleukin-8 mean value ±SEM in newborns with pneumonia was 346.75±36.84 pg/ml, andin non-infected 46.56±6.55 pg/ml; p=0.011. Comparing separately the groups of neonates with respiratory distress syndrome (RDS), transient tachypnoe of the newborn (TTN) and healthy ones with newborns with pneumonia we found out statistically significant differences in mean values of interleukin-6 and interleukin-8 but no other markers. There were no statistically significant differences in none of the parameters between the groups of neonates with RDS, TTN or healthy ones. Sensitivity and specificity for interleukin-6 level ?15.4pg/mL were 88.9% and 93.0% respectively, and area under the curve (AUC) 0.92 and for interleukin-8 level ?44pg/mL were 83.3%, 70.2%, 0.83. respectively. Diagnostic value of interleukin-6 and interleukin-8 was better than other routinely used markers of infection.Conclusions: Interleukin-6 and interleukin-8 are good diagnostic markers of early-onset neonatal pneumonia. Their sensitivity and interleukin’s-6 specificity exceed routinely used indices. They distinguish well between children with intrauterine pneumonia and respiratory disorders of non-infectious origin.
Keywords: intrauterine pneumonia, respiratory disorders, Interleukin-6, Interleukin-8
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952